Connect Biopharma Holdings (CNTB) Current Assets (2020 - 2026)

Connect Biopharma Holdings has disclosed Current Assets across 7 years of filings, most recently posting $38.6 million for Q2 2026.

• In Q2 2026, Current Assets fell 50.33% year-over-year to $38.6 million; the TTM figure through Jun 2026 stood at $38.6 million (down 50.33% YoY), while the FY2025 annual figure was $50.9 million, down 47.47% from the prior year.
• Current Assets came in at $38.6 million for Q2 2026 at Connect Biopharma Holdings, down from $55.0 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $197.8 million in Q2 2022 to a low of $38.6 million in Q2 2026.
• Average Current Assets over 5 years is $99.7 million, with a median of $92.4 million recorded in 2024.
• Year-over-year, Current Assets retreated 16.12% in 2024 and plunged 50.33% in 2026.
• Over 5 years, Current Assets stood at $152.5 million in 2022, then slipped by 19.66% to $122.6 million in 2023, then retreated by 20.88% to $97.0 million in 2024, then sank by 47.47% to $50.9 million in 2025, then decreased by 24.16% to $38.6 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $38.6 million in Q2 2026, $55.0 million in Q1 2026, and $50.9 million in Q4 2025.